Literature DB >> 24235263

Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.

Judith A Aberg1, Joel E Gallant, Khalil G Ghanem, Patricia Emmanuel, Barry S Zingman, Michael A Horberg.   

Abstract

Evidence-based guidelines for the management of persons infected with human immunodeficiency virus (HIV) were prepared by an expert panel of the HIV Medicine Association of the Infectious Diseases Society of America. These updated guidelines replace those published in 2009. The guidelines are intended for use by healthcare providers who care for HIV-infected patients. Since 2009, new antiretroviral drugs and classes have become available, and the prognosis of persons with HIV infection continues to improve. However, with fewer complications and increased survival, HIV-infected persons are increasingly developing common health problems that also affect the general population. Some of these conditions may be related to HIV infection itself or its treatment. HIV-infected persons should be managed and monitored for all relevant age- and sex-specific health problems. New information based on publications from the period 2009-2013 has been incorporated into this document.

Entities:  

Keywords:  HIV; HIV metabolic; HIV monitoring; HIV vaccines; guidelines; primary care; sexually transmitted diseases

Mesh:

Substances:

Year:  2013        PMID: 24235263     DOI: 10.1093/cid/cit665

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  126 in total

Review 1.  [Modern diagnosis of sexually transmitted diseases].

Authors:  N H Brockmeyer; T Meyer
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

Review 2.  Update on opportunistic infections in the era of effective antiretroviral therapy.

Authors:  Brian C Zanoni; Rajesh T Gandhi
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 3.  Endocrinological aspects of HIV infection.

Authors:  F S Mirza; P Luthra; L Chirch
Journal:  J Endocrinol Invest       Date:  2018-01-08       Impact factor: 4.256

4.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

Review 5.  Anal Intraepithelial Neoplasia from a Pathologists Point of View.

Authors:  Keegan M Lyons; Samantha L Butler
Journal:  Clin Colon Rectal Surg       Date:  2018-11-02

Review 6.  An immunization update for HIV-infected adults in the United States: review of the literature.

Authors:  Patricia A Cioe; Kathleen Melbourne; Jerome Larkin
Journal:  J Assoc Nurses AIDS Care       Date:  2015 Mar-Apr       Impact factor: 1.354

Review 7.  How to predict the risk of fracture in HIV?

Authors:  Michael T Yin; Julian Falutz
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

Review 8.  Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.

Authors:  Denise C Hsu; Irini Sereti
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

9.  Bacterial sexually transmitted infections among HIV-infected patients in the United States: estimates from the Medical Monitoring Project.

Authors:  Elaine W Flagg; Hillard S Weinstock; Emma L Frazier; Eduardo E Valverde; James D Heffelfinger; Jacek Skarbinski
Journal:  Sex Transm Dis       Date:  2015-04       Impact factor: 2.830

10.  Increased Sexually Transmitted Disease Testing Among Sexually Active Persons Receiving Medical Care for Human Immunodeficiency Virus Infection in the United States, 2009-2013.

Authors:  Christine L Mattson; Heather Bradley; Linda Beer; Christopher Johnson; William S Pearson; R Luke Shouse
Journal:  Clin Infect Dis       Date:  2017-03-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.